Identification and characterization of cancer vulnerabilities via targeted protein degradation
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Molecular Medicine
Reference91 articles.
1. Believe it or not: how much can we rely on published data on potential drug targets?;Prinz;Nat Rev Drug Discov,2011
2. Tackling reproducibility in academic preclinical drug discovery;Frye;Nat Rev Drug Discov,2015
3. An open investigation of the reproducibility of cancer biology research;Errington;Elife,2014
4. Common pitfalls in preclinical cancer target validation;Kaelin;Nat Rev Cancer,2017
5. Protacs: chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation;Sakamoto;Proc Natl Acad Sci U S A,2001
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Induced degradation of SNAP-fusion proteins;2024-07-18
2. Development and therapeutic potential of GSPT1 molecular glue degraders: A medicinal chemistry perspective;Medicinal Research Reviews;2024-02-05
3. Proteolysis-targeting chimeras in biotherapeutics: Current trends and future applications;European Journal of Medicinal Chemistry;2023-09
4. Biophysical and Computational Approaches to Study Ternary Complexes: A ‘Cooperative Relationship’ to Rationalize Targeted Protein Degradation;ChemBioChem;2023-04-21
5. A Perspective on Newly Emerging Proteolysis-Targeting Strategies in Antimicrobial Drug Discovery;Antibiotics;2022-11-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3